| GO(Gene Ontology) name | FDR corrected p-value |
|---|
| developmental process (GO:0032502) | 0 |
| cell part (GO:0044464) | 0 |
| multicellular organismal process (GO:0032501) | 0 |
| multicellular organismal development (GO:0007275) | 0 |
| intracellular part (GO:0044424) | 0 |
| system development (GO:0048731) | 0 |
| anatomical structure development (GO:0048856) | 0 |
| protein binding (GO:0005515) | 0 |
| nervous system development (GO:0007399) | 0 |
| biological regulation (GO:0065007) | 6.51817330378777e-71 |
| anatomical structure morphogenesis (GO:0009653) | 8.02194911335878e-69 |
| regulation of biological process (GO:0050789) | 7.19820170601254e-67 |
| cytoplasm (GO:0005737) | 4.68778282592248e-66 |
| cellular developmental process (GO:0048869) | 6.41192965174294e-63 |
| cell differentiation (GO:0030154) | 6.41192965174294e-63 |
| intracellular membrane-bound organelle (GO:0043231) | 4.47943956799549e-61 |
| intracellular (GO:0005622) | 4.67830086667686e-61 |
| membrane-bound organelle (GO:0043227) | 4.90759357750555e-61 |
| organ development (GO:0048513) | 5.81261157599243e-61 |
| organelle (GO:0043226) | 3.53575828201959e-56 |
| intracellular organelle (GO:0043229) | 5.11675706568663e-56 |
| regulation of cellular process (GO:0050794) | 1.00260394034344e-55 |
| negative regulation of cellular process (GO:0048523) | 2.58894676677497e-44 |
| negative regulation of biological process (GO:0048519) | 7.84664807440466e-44 |
| organ morphogenesis (GO:0009887) | 3.18790591511173e-42 |
| plasma membrane part (GO:0044459) | 4.61950924775731e-41 |
| membrane part (GO:0044425) | 7.1776684989173e-38 |
| regulation of transcription from RNA polymerase II promoter (GO:0006357) | 1.00226687880507e-37 |
| membrane (GO:0016020) | 1.2399603826116e-36 |
| neurogenesis (GO:0022008) | 4.76093765644259e-35 |
| embryonic development (GO:0009790) | 7.48232352636822e-35 |
| cell junction (GO:0030054) | 1.05683612368716e-34 |
| intrinsic to plasma membrane (GO:0031226) | 7.80970042403273e-34 |
| cellular component organization and biogenesis (GO:0016043) | 1.24554687159034e-33 |
| nucleus (GO:0005634) | 1.28644980594125e-33 |
| central nervous system development (GO:0007417) | 1.51464827668372e-33 |
| plasma membrane (GO:0005886) | 1.8263003281066e-33 |
| enzyme linked receptor protein signaling pathway (GO:0007167) | 3.06479542465368e-33 |
| generation of neurons (GO:0048699) | 3.06479542465368e-33 |
| localization of cell (GO:0051674) | 7.62650045447782e-33 |
| cell motility (GO:0006928) | 7.62650045447782e-33 |
| transcription from RNA polymerase II promoter (GO:0006366) | 1.22316028095213e-32 |
| integral to plasma membrane (GO:0005887) | 3.79821941568929e-32 |
| cell development (GO:0048468) | 1.00913298746167e-31 |
| cell communication (GO:0007154) | 2.75659351031397e-31 |
| regulation of metabolic process (GO:0019222) | 1.45794919665458e-30 |
| positive regulation of biological process (GO:0048518) | 3.81597494570868e-30 |
| cell morphogenesis (GO:0000902) | 6.22442587151096e-29 |
| cellular structure morphogenesis (GO:0032989) | 6.22442587151096e-29 |
| intrinsic to membrane (GO:0031224) | 6.24845551006154e-29 |
| positive regulation of cellular process (GO:0048522) | 2.52187259211265e-28 |
| integral to membrane (GO:0016021) | 4.14037946193696e-28 |
| regulation of cellular metabolic process (GO:0031323) | 3.38364055860963e-27 |
| membrane fraction (GO:0005624) | 7.47345613478813e-27 |
| transcription factor binding (GO:0008134) | 8.10141357932851e-27 |
| brain development (GO:0007420) | 1.749980949299e-26 |
| cell-cell signaling (GO:0007267) | 7.85092492866156e-26 |
| regulation of transcription, DNA-dependent (GO:0006355) | 9.97314981352818e-26 |
| blood vessel morphogenesis (GO:0048514) | 1.16842305028853e-25 |
| cell migration (GO:0016477) | 2.60506393516841e-25 |
| regulation of gene expression (GO:0010468) | 3.5138701246604e-25 |
| neuron differentiation (GO:0030182) | 3.5138701246604e-25 |
| alkali metal ion binding (GO:0031420) | 3.83990602875354e-25 |
| cell proliferation (GO:0008283) | 5.74370982726846e-25 |
| vasculature development (GO:0001944) | 6.6659907204831e-25 |
| localization (GO:0051179) | 1.03075618998494e-24 |
| transcription, DNA-dependent (GO:0006351) | 1.36236930967108e-24 |
| RNA biosynthetic process (GO:0032774) | 1.89844004114168e-24 |
| regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process (GO:0019219) | 2.26028798530366e-24 |
| blood vessel development (GO:0001568) | 4.67635280895369e-24 |
| cell fraction (GO:0000267) | 9.55161794766111e-24 |
| pattern specification process (GO:0007389) | 2.18745571406774e-23 |
| regulation of transcription (GO:0045449) | 2.48657386630489e-23 |
| neuron development (GO:0048666) | 1.8738461621017e-22 |
| signal transduction (GO:0007165) | 1.70397767385137e-21 |
| transcription (GO:0006350) | 4.51141109005841e-21 |
| transcription cofactor activity (GO:0003712) | 2.05642064651673e-20 |
| RNA metabolic process (GO:0016070) | 1.02287052572604e-19 |
| transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169) | 1.92207323546541e-19 |
| synaptic transmission (GO:0007268) | 2.84964776644248e-19 |
| proteinaceous extracellular matrix (GO:0005578) | 4.34246050885215e-19 |
| transcription repressor activity (GO:0016564) | 8.92501621560175e-19 |
| transmission of nerve impulse (GO:0019226) | 1.21839244549159e-18 |
| muscle development (GO:0007517) | 1.54888239358459e-18 |
| cell projection (GO:0042995) | 3.95841392207601e-18 |
| neurite development (GO:0031175) | 1.06656099364443e-17 |
| regionalization (GO:0003002) | 1.16660826086128e-17 |
| biopolymer metabolic process (GO:0043283) | 1.38838239131074e-17 |
| regulation of cell proliferation (GO:0042127) | 1.7749782828142e-17 |
| positive regulation of transcription (GO:0045941) | 3.93914652186817e-17 |
| enzyme binding (GO:0019899) | 1.48121549018752e-16 |
| ion binding (GO:0043167) | 1.51259264716563e-16 |
| regulation of developmental process (GO:0050793) | 1.83538722526875e-16 |
| neuron projection (GO:0043005) | 2.09196627939722e-16 |
| cell projection organization and biogenesis (GO:0030030) | 2.6710459124322e-16 |
| cell projection morphogenesis (GO:0048858) | 2.6710459124322e-16 |
| cell part morphogenesis (GO:0032990) | 2.6710459124322e-16 |
| potassium ion binding (GO:0030955) | 3.0722365363654e-16 |
| Golgi apparatus (GO:0005794) | 4.73086785289123e-16 |
| neuron morphogenesis during differentiation (GO:0048667) | 5.39671769770926e-16 |
| neurite morphogenesis (GO:0048812) | 5.39671769770926e-16 |
| positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process (GO:0045935) | 5.88711894384664e-16 |
| metal ion binding (GO:0046872) | 5.95579346991922e-16 |
| cellular morphogenesis during differentiation (GO:0000904) | 6.09496201081219e-16 |
| intracellular signaling cascade (GO:0007242) | 7.81414765787047e-16 |
| negative regulation of transcription (GO:0016481) | 9.71712280034393e-16 |
| heart development (GO:0007507) | 1.18253930322506e-15 |
| negative regulation of metabolic process (GO:0009892) | 1.25903084961742e-15 |
| positive regulation of transcription, DNA-dependent (GO:0045893) | 1.6515011658922e-15 |
| positive regulation of metabolic process (GO:0009893) | 1.83020197443107e-15 |
| transcription activator activity (GO:0016563) | 2.27673982184872e-15 |
| regulation of biological quality (GO:0065008) | 3.54551234164857e-15 |
| endomembrane system (GO:0012505) | 3.79795190814944e-15 |
| transcription corepressor activity (GO:0003714) | 3.91739658461942e-15 |
| endoplasmic reticulum part (GO:0044432) | 9.05860878986672e-15 |
| magnesium ion binding (GO:0000287) | 9.81287599995048e-15 |
| protein kinase cascade (GO:0007243) | 9.88306713597341e-15 |
| RNA polymerase II transcription factor activity (GO:0003702) | 1.13004304535654e-14 |
| skeletal development (GO:0001501) | 1.15468056781739e-14 |
| DNA binding (GO:0003677) | 1.17053381769575e-14 |
| transcription factor activity (GO:0003700) | 1.60070614143294e-14 |
| identical protein binding (GO:0042802) | 1.98612958746435e-14 |
| biological adhesion (GO:0022610) | 1.98855907974328e-14 |
| cell adhesion (GO:0007155) | 1.98855907974328e-14 |
| extracellular region part (GO:0044421) | 1.04889545723369e-13 |
| primary metabolic process (GO:0044238) | 1.24772753198392e-13 |
| negative regulation of cellular metabolic process (GO:0031324) | 1.26368671985611e-13 |
| negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process (GO:0045934) | 1.26667685207649e-13 |
| sensory organ development (GO:0007423) | 1.46223269699466e-13 |
| transport (GO:0006810) | 1.4819339670061e-13 |
| post-translational protein modification (GO:0043687) | 1.65416919196319e-13 |
| positive regulation of transcription from RNA polymerase II promoter (GO:0045944) | 1.89737615718392e-13 |
| transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178) | 2.10280120424423e-13 |
| negative regulation of transcription from RNA polymerase II promoter (GO:0000122) | 2.10543914852627e-13 |
| anatomical structure formation (GO:0048646) | 3.20803847088914e-13 |
| establishment of localization (GO:0051234) | 3.40957355995909e-13 |
| blood circulation (GO:0008015) | 3.85415873951306e-13 |
| circulatory system process (GO:0003013) | 3.85415873951306e-13 |
| regulation of locomotion (GO:0040012) | 4.49601485853291e-13 |
| angiogenesis (GO:0001525) | 4.80927145617908e-13 |
| positive regulation of cellular metabolic process (GO:0031325) | 5.25190203026525e-13 |
| cytoplasmic part (GO:0044444) | 7.0971707127927e-13 |
| locomotion (GO:0040011) | 8.53730680333793e-13 |
| MAPKKK cascade (GO:0000165) | 1.08954657607322e-12 |
| cellular metabolic process (GO:0044237) | 1.36692786055952e-12 |
| cytoskeleton (GO:0005856) | 1.49920822036351e-12 |
| sodium ion binding (GO:0031402) | 1.5626106893571e-12 |
| Wnt receptor signaling pathway (GO:0016055) | 1.81195941328079e-12 |
| axonogenesis (GO:0007409) | 1.87376456966567e-12 |
| protein modification process (GO:0006464) | 3.88754051392314e-12 |
| embryonic morphogenesis (GO:0048598) | 6.25762194361334e-12 |
| negative regulation of transcription, DNA-dependent (GO:0045892) | 6.43381949484305e-12 |
| cation binding (GO:0043169) | 1.03781426858429e-11 |
| metal ion transmembrane transporter activity (GO:0046873) | 1.07127463102454e-11 |
| organelle part (GO:0044422) | 1.14796272600993e-11 |
| extracellular matrix part (GO:0044420) | 1.23802803092497e-11 |
| muscle contraction (GO:0006936) | 1.80962780751025e-11 |
| muscle system process (GO:0003012) | 1.80962780751025e-11 |
| intracellular organelle part (GO:0044446) | 1.89841576815659e-11 |
| organelle membrane (GO:0031090) | 3.3227850941144e-11 |
| basement membrane (GO:0005604) | 3.90395550971185e-11 |
| synapse part (GO:0044456) | 4.28227656142825e-11 |
| regulation of cell motility (GO:0051270) | 5.0086209225416e-11 |
| biopolymer modification (GO:0043412) | 5.76061605536388e-11 |
| cell death (GO:0008219) | 5.76061605536388e-11 |
| death (GO:0016265) | 5.76061605536388e-11 |
| metal ion transport (GO:0030001) | 5.79163578435621e-11 |
| tube development (GO:0035295) | 8.11201994107028e-11 |
| cation channel activity (GO:0005261) | 9.27691478524189e-11 |
| cell fate commitment (GO:0045165) | 1.57530835559112e-10 |
| gated channel activity (GO:0022836) | 2.59610340366538e-10 |
| endoplasmic reticulum (GO:0005783) | 2.79545762147308e-10 |
| regulation of neurotransmitter levels (GO:0001505) | 3.28550383183164e-10 |
| system process (GO:0003008) | 4.09454527847072e-10 |
| programmed cell death (GO:0012501) | 4.14689773968235e-10 |
| cell-substrate adhesion (GO:0031589) | 5.35668148499274e-10 |
| regulation of cell size (GO:0008361) | 5.51691176422093e-10 |
| protein complex assembly (GO:0006461) | 6.14835890863233e-10 |
| nucleobase, nucleoside, nucleotide and nucleic acid metabolic process (GO:0006139) | 6.56963120467125e-10 |
| ubiquitin cycle (GO:0006512) | 7.20745710638367e-10 |
| apoptosis (GO:0006915) | 1.25847112653307e-09 |
| cell-matrix adhesion (GO:0007160) | 1.29776022737031e-09 |
| negative regulation of cell proliferation (GO:0008285) | 1.36044407197763e-09 |
| potassium ion transport (GO:0006813) | 1.38105926201278e-09 |
| cytoskeleton organization and biogenesis (GO:0007010) | 1.70383799031819e-09 |
| endoplasmic reticulum membrane (GO:0005789) | 1.73138722210699e-09 |
| Golgi membrane (GO:0000139) | 2.28864149171757e-09 |
| macromolecule metabolic process (GO:0043170) | 2.94037247683665e-09 |
| Golgi apparatus part (GO:0044431) | 3.78858444134641e-09 |
| voltage-gated cation channel activity (GO:0022843) | 5.25000981346853e-09 |
| nuclear envelope-endoplasmic reticulum network (GO:0042175) | 5.49612619739605e-09 |
| vesicle (GO:0031982) | 5.77871232876579e-09 |
| transcription coactivator activity (GO:0003713) | 6.77678527383801e-09 |
| cytoplasmic vesicle (GO:0031410) | 7.29855806576918e-09 |
| voltage-gated channel activity (GO:0022832) | 8.36603514170722e-09 |
| voltage-gated ion channel activity (GO:0005244) | 8.36603514170722e-09 |
| negative regulation of apoptosis (GO:0043066) | 1.0179634123548e-08 |
| axon (GO:0030424) | 1.16960135456017e-08 |
| synaptic vesicle (GO:0008021) | 1.27630141417358e-08 |
| negative regulation of programmed cell death (GO:0043069) | 1.84452426552105e-08 |
| regulation of cellular component organization and biogenesis (GO:0051128) | 2.05247835772991e-08 |
| cell surface (GO:0009986) | 2.20066071396101e-08 |
| cell growth (GO:0016049) | 2.82535748303419e-08 |
| heparin binding (GO:0008201) | 3.12260824613357e-08 |
| regulation of programmed cell death (GO:0043067) | 3.89070076297223e-08 |
| protein homodimerization activity (GO:0042803) | 4.49636194351227e-08 |
| membrane organization and biogenesis (GO:0016044) | 4.86196243652584e-08 |
| regulation of cell differentiation (GO:0045595) | 5.07211577341653e-08 |
| voltage-gated potassium channel complex (GO:0008076) | 5.24530340386903e-08 |
| actin filament-based process (GO:0030029) | 5.39981465030137e-08 |
| regulation of apoptosis (GO:0042981) | 5.39981465030137e-08 |
| tube morphogenesis (GO:0035239) | 6.55052985357982e-08 |
| cytoplasmic membrane-bound vesicle (GO:0016023) | 8.22111829699246e-08 |
| ion transport (GO:0006811) | 8.46780354364599e-08 |
| actin cytoskeleton (GO:0015629) | 8.49953803895308e-08 |
| chromatin binding (GO:0003682) | 9.08954749077776e-08 |
| actin cytoskeleton organization and biogenesis (GO:0030036) | 9.45691397287519e-08 |
| basolateral plasma membrane (GO:0016323) | 9.48644556126025e-08 |
| regulation of cell growth (GO:0001558) | 1.14234799996126e-07 |
| sequence-specific DNA binding (GO:0043565) | 1.20187834703781e-07 |
| kinase binding (GO:0019900) | 1.35833037905497e-07 |
| membrane-bound vesicle (GO:0031988) | 1.59643871508887e-07 |
| stress-activated protein kinase signaling pathway (GO:0031098) | 1.80355847277915e-07 |
| monovalent inorganic cation transport (GO:0015672) | 2.29355059620235e-07 |
| vesicle-mediated transport (GO:0016192) | 2.75425146491301e-07 |
| tight junction (GO:0005923) | 4.07951368624091e-07 |
| gene expression (GO:0010467) | 4.68903217105055e-07 |
| ion channel activity (GO:0005216) | 5.04870396104057e-07 |
| cytoskeletal protein binding (GO:0008092) | 5.04870396104057e-07 |
| regulation of growth (GO:0040008) | 6.21407643928126e-07 |
| anti-apoptosis (GO:0006916) | 6.69798647512773e-07 |
| extracellular structure organization and biogenesis (GO:0043062) | 6.9028404329248e-07 |
| regulation of cell migration (GO:0030334) | 6.9445152067245e-07 |
| passive transmembrane transporter activity (GO:0022803) | 8.9210237331576e-07 |
| channel activity (GO:0015267) | 8.9210237331576e-07 |
| substrate specific channel activity (GO:0022838) | 9.58447434406076e-07 |
| postsynaptic membrane (GO:0045211) | 9.96908831897018e-07 |
| regulation of signal transduction (GO:0009966) | 1.0145532293396e-06 |
| transmembrane receptor protein kinase activity (GO:0019199) | 1.04751081801385e-06 |
| transforming growth factor beta receptor signaling pathway (GO:0007179) | 1.0734475273353e-06 |
| regulation of cell cycle (GO:0051726) | 1.18832802798173e-06 |
| intercellular junction (GO:0005911) | 1.20718676341382e-06 |
| potassium channel activity (GO:0005267) | 1.21586368894843e-06 |
| sensory perception of light stimulus (GO:0050953) | 1.64317894031248e-06 |
| visual perception (GO:0007601) | 1.64317894031248e-06 |
| cation transport (GO:0006812) | 1.79364813201695e-06 |
| cell cycle (GO:0007049) | 1.8173186259579e-06 |
| positive regulation of cell proliferation (GO:0008284) | 2.15293196665411e-06 |
| negative regulation of progression through cell cycle (GO:0045786) | 2.26839266740167e-06 |
| vasculogenesis (GO:0001570) | 2.29962633943365e-06 |
| extracellular matrix structural constituent (GO:0005201) | 2.33345469135988e-06 |
| embryonic development ending in birth or egg hatching (GO:0009792) | 2.63863568391316e-06 |
| chordate embryonic development (GO:0043009) | 2.63863568391316e-06 |
| protein dimerization activity (GO:0046983) | 2.65065217620246e-06 |
| macromolecule localization (GO:0033036) | 2.81106399332184e-06 |
| chromatin modification (GO:0016568) | 3.25210578581702e-06 |
| coated vesicle (GO:0030135) | 3.26039221631274e-06 |
| positive regulation of transferase activity (GO:0051347) | 3.26039221631274e-06 |
| insulin receptor signaling pathway (GO:0008286) | 3.26081694773906e-06 |
| glycosaminoglycan binding (GO:0005539) | 3.35175095077168e-06 |
| calcium ion binding (GO:0005509) | 3.63818082195041e-06 |
| cation transmembrane transporter activity (GO:0008324) | 3.79959729568204e-06 |
| embryonic pattern specification (GO:0009880) | 4.70726133411205e-06 |
| regulation of transferase activity (GO:0051338) | 4.82332916276115e-06 |
| endocytosis (GO:0006897) | 5.02048604213189e-06 |
| membrane invagination (GO:0010324) | 5.02048604213189e-06 |
| sodium ion transport (GO:0006814) | 5.27409288464091e-06 |
| negative regulation of developmental process (GO:0051093) | 5.28598442318389e-06 |
| protein domain specific binding (GO:0019904) | 5.84217393435243e-06 |
| axon guidance (GO:0007411) | 6.14215678098968e-06 |
| cellular localization (GO:0051641) | 7.86020098678298e-06 |
| positive regulation of kinase activity (GO:0033674) | 8.58358447874152e-06 |
| establishment of cellular localization (GO:0051649) | 9.86931007318392e-06 |
| gastrulation (GO:0007369) | 1.03590125734231e-05 |
| protein localization (GO:0008104) | 1.06137505375223e-05 |
| clathrin-coated vesicle (GO:0030136) | 1.1491286966444e-05 |
| regulation of progression through cell cycle (GO:0000074) | 1.30217215742594e-05 |
| polysaccharide binding (GO:0030247) | 1.45703153554332e-05 |
| sensory perception of mechanical stimulus (GO:0050954) | 1.74964786603949e-05 |
| sensory perception of sound (GO:0007605) | 1.74964786603949e-05 |
| blood vessel remodeling (GO:0001974) | 1.74964786603949e-05 |
| ear development (GO:0043583) | 1.76043381196801e-05 |
| regulation of protein metabolic process (GO:0051246) | 1.81735790549977e-05 |
| ubiquitin-protein ligase activity (GO:0004842) | 1.88479363324988e-05 |
| collagen fibril organization (GO:0030199) | 1.92042113890783e-05 |
| lipid binding (GO:0008289) | 1.93490515600651e-05 |
| apical junction complex (GO:0043296) | 2.19782174250803e-05 |
| positive regulation of protein kinase activity (GO:0045860) | 2.20216224224088e-05 |
| voltage-gated potassium channel activity (GO:0005249) | 2.22230691401341e-05 |
| SH3/SH2 adaptor activity (GO:0005070) | 2.43572985682739e-05 |
| regulation of kinase activity (GO:0043549) | 2.60515421568838e-05 |
| small protein conjugating enzyme activity (GO:0008639) | 2.64040291381366e-05 |
| phosphoinositide binding (GO:0035091) | 2.67198736977677e-05 |
| reproductive process (GO:0022414) | 2.75710594547124e-05 |
| inner ear development (GO:0048839) | 2.90018662135816e-05 |
| actin binding (GO:0003779) | 3.21531871010867e-05 |
| postsynaptic density (GO:0014069) | 3.39101688789024e-05 |
| epithelial cell proliferation (GO:0050673) | 3.39840118902993e-05 |
| apicolateral plasma membrane (GO:0016327) | 3.49536787272234e-05 |
| protein amino acid phosphorylation (GO:0006468) | 3.56265818411637e-05 |
| dorsal/ventral pattern formation (GO:0009953) | 3.66947230058331e-05 |
| generation of a signal involved in cell-cell signaling (GO:0003001) | 4.06030797382076e-05 |
| regulation of protein kinase activity (GO:0045859) | 4.22171462217079e-05 |
| endoplasmic reticulum lumen (GO:0005788) | 4.3127992036846e-05 |
| gamete generation (GO:0007276) | 4.43207075951465e-05 |
| vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 4.59503994310337e-05 |
| lipid metabolic process (GO:0006629) | 4.79016375956074e-05 |
| positive regulation of catalytic activity (GO:0043085) | 4.95001965657812e-05 |
| neurotransmitter secretion (GO:0007269) | 5.33471931702223e-05 |
| JNK cascade (GO:0007254) | 5.33471931702223e-05 |
| extracellular matrix organization and biogenesis (GO:0030198) | 5.45323463254432e-05 |
| smooth muscle cell differentiation (GO:0051145) | 5.90201142570225e-05 |
| protein transport (GO:0015031) | 6.37679545832834e-05 |
| manganese ion binding (GO:0030145) | 6.54862240904133e-05 |
| regulation of MAP kinase activity (GO:0043405) | 6.64642650070668e-05 |
| regulation of multicellular organismal process (GO:0051239) | 7.0220435613865e-05 |
| heart contraction (GO:0060047) | 7.08105616521341e-05 |
| heart process (GO:0003015) | 7.08105616521341e-05 |
| establishment of protein localization (GO:0045184) | 7.30753126409219e-05 |
| tissue development (GO:0009888) | 7.36273910116268e-05 |
| molecular adaptor activity (GO:0060090) | 7.52097069154728e-05 |
| regulation of epithelial cell proliferation (GO:0050678) | 7.60530292180378e-05 |
| phospholipid binding (GO:0005543) | 8.19144194962318e-05 |
| adherens junction (GO:0005912) | 8.41931168843314e-05 |
| neuron migration (GO:0001764) | 8.9293182789172e-05 |
| ion transmembrane transporter activity (GO:0015075) | 9.30040231203828e-05 |
| actin polymerization and/or depolymerization (GO:0008154) | 9.30040231203828e-05 |
| lung development (GO:0030324) | 9.30040231203828e-05 |
| heart morphogenesis (GO:0003007) | 9.41701605881539e-05 |
| protein kinase activator activity (GO:0030295) | 9.5861081639895e-05 |
| regulation of transport (GO:0051049) | 0.000101934723277655 |
| anterior/posterior pattern formation (GO:0009952) | 0.000105300707413359 |
| GPI anchor binding (GO:0048503) | 0.000110316567249302 |
| striated muscle development (GO:0014706) | 0.000114411539538015 |
| glutamate signaling pathway (GO:0007215) | 0.000118426101783029 |
| respiratory tube development (GO:0030323) | 0.000121362066843314 |
| protein serine/threonine kinase activity (GO:0004674) | 0.000124806675445828 |
| pattern binding (GO:0001871) | 0.000132595125181754 |
| negative regulation of signal transduction (GO:0009968) | 0.000144219348363115 |
| receptor signaling protein activity (GO:0005057) | 0.000144219348363115 |
| morphogenesis of a branching structure (GO:0001763) | 0.000147802182190956 |
| microtubule cytoskeleton (GO:0015630) | 0.000149866815448036 |
| learning and/or memory (GO:0007611) | 0.000156911602006255 |
| protein amino acid autophosphorylation (GO:0046777) | 0.000156911602006255 |
| behavior (GO:0007610) | 0.000157834941083957 |
| learning (GO:0007612) | 0.000157834941083957 |
| mesoderm morphogenesis (GO:0048332) | 0.000157834941083957 |
| positive regulation of developmental process (GO:0051094) | 0.000164550676603166 |
| RNA polymerase II transcription factor activity, enhancer binding (GO:0003705) | 0.000170053440497669 |
| cell surface receptor linked signal transduction (GO:0007166) | 0.00017542525702475 |
| cell cycle process (GO:0022402) | 0.000220093518014645 |
| kinase regulator activity (GO:0019207) | 0.000228025613890639 |
| protein binding, bridging (GO:0030674) | 0.000228711917019542 |
| substrate-specific transporter activity (GO:0022892) | 0.000238170941052577 |
| phosphorus metabolic process (GO:0006793) | 0.000238170941052577 |
| phosphate metabolic process (GO:0006796) | 0.000238170941052577 |
| branching morphogenesis of a tube (GO:0048754) | 0.000241384978508834 |
| organelle organization and biogenesis (GO:0006996) | 0.000241384978508834 |
| protein processing (GO:0016485) | 0.000247744996289939 |
| muscle cell differentiation (GO:0042692) | 0.00025478963000695 |
| protein autoprocessing (GO:0016540) | 0.00025478963000695 |
| axis specification (GO:0009798) | 0.00025478963000695 |
| neurological system process (GO:0050877) | 0.000267200257900113 |
| receptor signaling protein serine/threonine kinase activity (GO:0004702) | 0.000269031769907048 |
| basal lamina (GO:0005605) | 0.000269031769907048 |
| regulated secretory pathway (GO:0045055) | 0.0002843113440248 |
| peroxisome (GO:0005777) | 0.000301804750811906 |
| microbody (GO:0042579) | 0.000301804750811906 |
| eye development (GO:0001654) | 0.000319870396549162 |
| regulation of actin cytoskeleton organization and biogenesis (GO:0032956) | 0.000319870396549162 |
| regulation of cellular component size (GO:0032535) | 0.000319870396549162 |
| cellular component assembly (GO:0022607) | 0.000345356418272957 |
| behavioral defense response (GO:0002209) | 0.00036347314896152 |
| behavioral fear response (GO:0001662) | 0.00036347314896152 |
| G-protein activated inward rectifier potassium channel activity (GO:0015467) | 0.00036347314896152 |
| mesenchymal cell development (GO:0014031) | 0.000382418390951872 |
| mesenchymal cell differentiation (GO:0048762) | 0.000382418390951872 |
| apical part of cell (GO:0045177) | 0.000390207562559939 |
| response to hypoxia (GO:0001666) | 0.000400490042405916 |
| regulation of heart contraction (GO:0008016) | 0.000441780259288039 |
| regulation of cell morphogenesis (GO:0022604) | 0.000441780259288039 |
| regulation of anatomical structure morphogenesis (GO:0022603) | 0.000441780259288039 |
| regulation of cell shape (GO:0008360) | 0.000441780259288039 |
| organelle lumen (GO:0043233) | 0.000452954034173039 |
| membrane-enclosed lumen (GO:0031974) | 0.000452954034173039 |
| sexual reproduction (GO:0019953) | 0.000469359219524286 |
| secretory pathway (GO:0045045) | 0.00047387148883183 |
| negative regulation of catalytic activity (GO:0043086) | 0.000480392289253617 |
| cAMP-mediated signaling (GO:0019933) | 0.000480392289253617 |
| fear response (GO:0042596) | 0.000480964206594422 |
| secretion by cell (GO:0032940) | 0.000516013393182903 |
| regulation of cytoskeleton organization and biogenesis (GO:0051493) | 0.000518251605787548 |
| regulation of organelle organization and biogenesis (GO:0033043) | 0.000518251605787548 |
| mesoderm formation (GO:0001707) | 0.00053650129582673 |
| coated pit (GO:0005905) | 0.000554500143383112 |
| protein complex (GO:0043234) | 0.000559156957091437 |
| microtubule (GO:0005874) | 0.000561824729675637 |
| Notch signaling pathway (GO:0007219) | 0.00061027856643497 |
| contractile fiber (GO:0043292) | 0.000623382687370501 |
| dopamine metabolic process (GO:0042417) | 0.000626211072361159 |
| patterning of blood vessels (GO:0001569) | 0.000626211072361159 |
| protein serine/threonine phosphatase complex (GO:0008287) | 0.000626211072361159 |
| substrate-specific transmembrane transporter activity (GO:0022891) | 0.00065645896761817 |
| protein kinase activity (GO:0004672) | 0.000664399217004956 |
| growth factor activity (GO:0008083) | 0.00069029412915291 |
| mesoderm development (GO:0007498) | 0.000692204933125329 |
| receptor binding (GO:0005102) | 0.000713786520473481 |
| growth factor binding (GO:0019838) | 0.00072194005325514 |
| negative regulation of cell differentiation (GO:0045596) | 0.000736996550359025 |
| GTPase binding (GO:0051020) | 0.000752490923729058 |
| GTPase regulator activity (GO:0030695) | 0.000752490923729058 |
| dendrite (GO:0030425) | 0.000753749328843147 |
| regulation of angiogenesis (GO:0045765) | 0.000753749328843147 |
| tissue remodeling (GO:0048771) | 0.000757732701658182 |
| phosphoric diester hydrolase activity (GO:0008081) | 0.000772639526486951 |
| aminoglycan biosynthetic process (GO:0006023) | 0.000840786131932039 |
| SNARE binding (GO:0000149) | 0.000840786131932039 |
| zinc ion binding (GO:0008270) | 0.000849238707147391 |
| nucleoplasm part (GO:0044451) | 0.000876268741494481 |
| cellular lipid metabolic process (GO:0044255) | 0.000890706717837622 |
| transmembrane transporter activity (GO:0022857) | 0.000901233136821038 |
| ubiquitin ligase complex (GO:0000151) | 0.00101276135340359 |
| skeletal muscle development (GO:0007519) | 0.00102752309576869 |
| secretion (GO:0046903) | 0.00105492620924333 |
| forebrain development (GO:0030900) | 0.00105492620924333 |
| regulation of actin filament length (GO:0030832) | 0.00105492620924333 |
| contractile fiber part (GO:0044449) | 0.00107237421182564 |
| multicellular organismal response to stress (GO:0033555) | 0.00109431515495798 |
| presynaptic membrane (GO:0042734) | 0.00109431515495798 |
| positive regulation of programmed cell death (GO:0043068) | 0.00110167482402862 |
| calmodulin binding (GO:0005516) | 0.0011891029009225 |
| G-protein signaling, coupled to cAMP nucleotide second messenger (GO:0007188) | 0.00123662850000693 |
| regulation of ion transport (GO:0043269) | 0.00128565695783761 |
| formation of primary germ layer (GO:0001704) | 0.00128565695783761 |
| positive regulation of cell differentiation (GO:0045597) | 0.00129461575522271 |
| focal adhesion (GO:0005925) | 0.00130724894276028 |
| inorganic anion transport (GO:0015698) | 0.00133082519305486 |
| regulation of catalytic activity (GO:0050790) | 0.00137226266391629 |
| Ras GTPase binding (GO:0017016) | 0.00141674675233152 |
| macromolecular complex assembly (GO:0065003) | 0.00141875079791925 |
| intracellular transport (GO:0046907) | 0.00144812299935606 |
| GTP-Rho binding (GO:0017049) | 0.00144943639728554 |
| integrin binding (GO:0005178) | 0.00149134671832022 |
| transmembrane receptor protein tyrosine kinase activity (GO:0004714) | 0.00149134671832022 |
| small GTPase binding (GO:0031267) | 0.00149197220242096 |
| focal adhesion formation (GO:0048041) | 0.00183325052940234 |
| sulfur metabolic process (GO:0006790) | 0.00183416415473559 |
| kinase activator activity (GO:0019209) | 0.00189628546259225 |
| positive regulation of epithelial cell proliferation (GO:0050679) | 0.00189628546259225 |
| transforming growth factor beta receptor activity (GO:0005024) | 0.00189628546259225 |
| transmembrane receptor protein serine/threonine kinase activity (GO:0004675) | 0.00189628546259225 |
| transition metal ion binding (GO:0046914) | 0.00190796928876172 |
| cartilage development (GO:0051216) | 0.00212795523398316 |
| positive regulation of apoptosis (GO:0043065) | 0.00222634465853014 |
| cytoplasm organization and biogenesis (GO:0007028) | 0.00227523373853276 |
| ER-Golgi intermediate compartment (GO:0005793) | 0.00230336973680142 |
| N-methyltransferase activity (GO:0008170) | 0.00232633749639378 |
| protein serine/threonine phosphatase activity (GO:0004722) | 0.00247780034098762 |
| phosphoric ester hydrolase activity (GO:0042578) | 0.00258050219687474 |
| regulation of a molecular function (GO:0065009) | 0.00263077373313006 |
| ossification (GO:0001503) | 0.0026527043063725 |
| G-protein signaling, coupled to IP3 second messenger (phospholipase C activating) (GO:0007200) | 0.0026527043063725 |
| biomineral formation (GO:0031214) | 0.0026527043063725 |
| voltage-gated calcium channel complex (GO:0005891) | 0.00265418546125206 |
| odontogenesis of dentine-containing teeth (GO:0042475) | 0.00270511598820549 |
| collagen binding (GO:0005518) | 0.00270511598820549 |
| syntaxin binding (GO:0019905) | 0.00270511598820549 |
| second-messenger-mediated signaling (GO:0019932) | 0.00270511598820549 |
| regulation of actin polymerization and/or depolymerization (GO:0008064) | 0.00277705375784166 |
| phosphorylation (GO:0016310) | 0.00289753380450888 |
| negative regulation of transport (GO:0051051) | 0.0029133365914416 |
| ear morphogenesis (GO:0042471) | 0.0029133365914416 |
| protein kinase regulator activity (GO:0019887) | 0.00295046165431182 |
| cyclic nucleotide binding (GO:0030551) | 0.00298756670445732 |
| cyclic-nucleotide-mediated signaling (GO:0019935) | 0.00300311819522394 |
| cell-substrate adherens junction (GO:0005924) | 0.00326748661693723 |
| small GTPase regulator activity (GO:0005083) | 0.00326991847897602 |
| phosphotransferase activity, alcohol group as acceptor (GO:0016773) | 0.00337893326466934 |
| protein metabolic process (GO:0019538) | 0.00343401754980668 |
| microtubule polymerization or depolymerization (GO:0031109) | 0.00370648534161792 |
| stem cell differentiation (GO:0048863) | 0.00370648534161792 |
| protein-arginine N-methyltransferase activity (GO:0016274) | 0.00370648534161792 |
| activin receptor activity (GO:0017002) | 0.00370648534161792 |
| negative regulation of hydrolase activity (GO:0051346) | 0.00370648534161792 |
| segment specification (GO:0007379) | 0.00370648534161792 |
| arginine N-methyltransferase activity (GO:0016273) | 0.00370648534161792 |
| sperm motility (GO:0030317) | 0.00370877764140127 |
| glycosaminoglycan biosynthetic process (GO:0006024) | 0.00370877764140127 |
| RNA stabilization (GO:0043489) | 0.00370877764140127 |
| artery morphogenesis (GO:0048844) | 0.00370877764140127 |
| potassium ion transmembrane transporter activity (GO:0015079) | 0.00370877764140127 |
| mRNA stabilization (GO:0048255) | 0.00370877764140127 |
| laminin-1 complex (GO:0005606) | 0.00374776004168364 |
| spinal cord development (GO:0021510) | 0.00374776004168364 |
| myofibril (GO:0030016) | 0.00381648492714339 |
| inward rectifier potassium channel activity (GO:0005242) | 0.00386127340515389 |
| regulation of muscle contraction (GO:0006937) | 0.00393492236677624 |
| protein depolymerization (GO:0051261) | 0.00396157327027525 |
| nucleoplasm (GO:0005654) | 0.00397631938761282 |
| anion transport (GO:0006820) | 0.00412232429471584 |
| reproductive process in a multicellular organism (GO:0048609) | 0.00412613189795195 |
| multicellular organism reproduction (GO:0032504) | 0.00412613189795195 |
| non-G-protein coupled 7TM receptor activity (GO:0004926) | 0.00415049579469594 |
| protein kinase binding (GO:0019901) | 0.00438863908924565 |
| collagen (GO:0005581) | 0.00448982248813536 |
| microtubule-based process (GO:0007017) | 0.00478090358266855 |
| cell-matrix junction (GO:0030055) | 0.00478720649195284 |
| urogenital system development (GO:0001655) | 0.00478720649195284 |
| G-protein signaling, coupled to cyclic nucleotide second messenger (GO:0007187) | 0.00485410663279184 |
| regulation of Wnt receptor signaling pathway (GO:0030111) | 0.0049657386823827 |
| segmentation (GO:0035282) | 0.0049657386823827 |
| inner ear morphogenesis (GO:0042472) | 0.0049657386823827 |
| lactation (GO:0007595) | 0.00497091321084058 |
| apical plasma membrane (GO:0016324) | 0.00506061736913538 |
| mRNA binding (GO:0003729) | 0.00564874887550209 |
| camera-type eye development (GO:0043010) | 0.00564874887550209 |
| regulation of adenylate cyclase activity (GO:0045761) | 0.00581301731968564 |
| sarcolemma (GO:0042383) | 0.0060142394445911 |
| basal part of cell (GO:0045178) | 0.0060142394445911 |
| basal plasma membrane (GO:0009925) | 0.0060142394445911 |
| fibrillar collagen (GO:0005583) | 0.00610153162814492 |
| memory (GO:0007613) | 0.00610153162814492 |
| nuclear hormone receptor binding (GO:0035257) | 0.00613819954083583 |
| structural constituent of cytoskeleton (GO:0005200) | 0.0061570609508574 |
| cellular protein complex assembly (GO:0043623) | 0.0061570609508574 |
| guanyl-nucleotide exchange factor activity (GO:0005085) | 0.0063420769315657 |
| phosphatase binding (GO:0019902) | 0.00663619093890453 |
| two-component signal transduction system (phosphorelay) (GO:0000160) | 0.00663619093890453 |
| histone methyltransferase activity (GO:0042054) | 0.00689278375037451 |
| cell soma (GO:0043025) | 0.00689278375037451 |
| structural constituent of muscle (GO:0008307) | 0.00689278375037451 |
| regulation of lyase activity (GO:0051339) | 0.00689278375037451 |
| regulation of cyclase activity (GO:0031279) | 0.00689278375037451 |
| skeletal muscle fiber development (GO:0048741) | 0.00689278375037451 |
| muscle fiber development (GO:0048747) | 0.00689278375037451 |
| hormone receptor binding (GO:0051427) | 0.00708380799311083 |
| glucocorticoid metabolic process (GO:0008211) | 0.00730531742084999 |
| positive regulation of microtubule polymerization (GO:0031116) | 0.00730531742084999 |
| nitric-oxide synthase binding (GO:0050998) | 0.00730531742084999 |
| acetylcholine receptor signaling, muscarinic pathway (GO:0007213) | 0.00730531742084999 |
| regulation of smoothened signaling pathway (GO:0008589) | 0.00730531742084999 |
| zinc ion transmembrane transporter activity (GO:0005385) | 0.00730531742084999 |
| neurotransmitter transport (GO:0006836) | 0.00733732576143088 |
| cholesterol metabolic process (GO:0008203) | 0.00733732576143088 |
| in utero embryonic development (GO:0001701) | 0.00770011805204493 |
| establishment and/or maintenance of cell polarity (GO:0007163) | 0.0078466806092146 |
| cell fate determination (GO:0001709) | 0.0078466806092146 |
| regulation of microtubule polymerization or depolymerization (GO:0031110) | 0.0078466806092146 |
| glial cell differentiation (GO:0010001) | 0.0078466806092146 |
| positive regulation of cell migration (GO:0030335) | 0.00820599645309786 |
| neutral amino acid transmembrane transporter activity (GO:0015175) | 0.00820599645309786 |
| negative regulation of angiogenesis (GO:0016525) | 0.00820599645309786 |
| positive regulation of MAP kinase activity (GO:0043406) | 0.00822622762660688 |
| synaptosome (GO:0019717) | 0.0082499402642833 |
| negative regulation of protein metabolic process (GO:0051248) | 0.00846288255660298 |
| cytosol (GO:0005829) | 0.00907671165307345 |
| nuclear part (GO:0044428) | 0.00907671165307345 |
| bone remodeling (GO:0046849) | 0.00907671165307345 |
| negative regulation of nucleocytoplasmic transport (GO:0046823) | 0.00907671165307345 |
| ER-Golgi intermediate compartment membrane (GO:0033116) | 0.00907671165307345 |
| smooth endoplasmic reticulum (GO:0005790) | 0.00907671165307345 |
| palmitoyltransferase activity (GO:0016409) | 0.00907671165307345 |
| regulation of neurotransmitter secretion (GO:0046928) | 0.00907671165307345 |
| laminin complex (GO:0043256) | 0.00907671165307345 |
| regulation of anti-apoptosis (GO:0045767) | 0.00907671165307345 |
| protein catabolic process (GO:0030163) | 0.00927373491391709 |
| cytoplasmic vesicle membrane (GO:0030659) | 0.0096530694247335 |
| hormone metabolic process (GO:0042445) | 0.0096641544780351 |
| limb development (GO:0060173) | 0.00987764187353614 |
| appendage development (GO:0048736) | 0.00987764187353614 |
| appendage morphogenesis (GO:0035107) | 0.00987764187353614 |
| limb morphogenesis (GO:0035108) | 0.00987764187353614 |
| neurotransmitter receptor activity (GO:0030594) | 0.0101469352548915 |
| metal ion homeostasis (GO:0055065) | 0.0101469352548915 |
| cellular metal ion homeostasis (GO:0006875) | 0.0101469352548915 |
| cytoskeletal part (GO:0044430) | 0.0105654150840737 |
| anion binding (GO:0043168) | 0.0105654150840737 |
| chloride ion binding (GO:0031404) | 0.0105654150840737 |
| metanephros development (GO:0001656) | 0.0107732498665897 |
| determination of symmetry (GO:0009799) | 0.010923174522677 |
| determination of bilateral symmetry (GO:0009855) | 0.010923174522677 |
| determination of left/right symmetry (GO:0007368) | 0.010923174522677 |
| synaptic vesicle transport (GO:0048489) | 0.010923174522677 |
| BMP signaling pathway (GO:0030509) | 0.010923174522677 |
| cell-substrate junction assembly (GO:0007044) | 0.0115473001133516 |
| regulation of sodium ion transport (GO:0002028) | 0.0115473001133516 |
| regulation of dendrite development (GO:0050773) | 0.0115473001133516 |
| glucocorticoid receptor signaling pathway (GO:0042921) | 0.0115473001133516 |
| dihydropyrimidinase activity (GO:0004157) | 0.0115473001133516 |
| activin receptor activity, type I (GO:0016361) | 0.0115473001133516 |
| protein palmitoylation (GO:0018345) | 0.0115473001133516 |
| dopamine biosynthetic process (GO:0042416) | 0.0115473001133516 |
| corticosteroid receptor signaling pathway (GO:0031958) | 0.0115473001133516 |
| lymph vessel development (GO:0001945) | 0.0115473001133516 |
| regulation of muscle cell differentiation (GO:0051147) | 0.0115473001133516 |
| vascular endothelial growth factor receptor binding (GO:0005172) | 0.0115473001133516 |
| chromatin-mediated maintenance of transcription (GO:0048096) | 0.0115473001133516 |
| CCAAT-binding factor complex (GO:0016602) | 0.0115473001133516 |
| response to stress (GO:0006950) | 0.0117572680593416 |
| microtubule associated complex (GO:0005875) | 0.0117942885571313 |
| extrinsic to membrane (GO:0019898) | 0.0122155730614955 |
| cytoplasmic vesicle part (GO:0044433) | 0.0122155730614955 |
| SWI/SNF complex (GO:0016514) | 0.0122155730614955 |
| lamellipodium biogenesis (GO:0030032) | 0.0122155730614955 |
| mRNA 3'-UTR binding (GO:0003730) | 0.0122155730614955 |
| regulation of mRNA stability (GO:0043488) | 0.0122155730614955 |
| synaptic vesicle exocytosis (GO:0016079) | 0.0122155730614955 |
| regulation of embryonic development (GO:0045995) | 0.0122155730614955 |
| positive regulation of microtubule polymerization or depolymerization (GO:0031112) | 0.0122155730614955 |
| regulation of RNA stability (GO:0043487) | 0.0122155730614955 |
| regulation of microtubule polymerization (GO:0031113) | 0.0122155730614955 |
| cellular calcium ion homeostasis (GO:0006874) | 0.0123183651903867 |
| calcium ion homeostasis (GO:0055074) | 0.0123183651903867 |
| negative regulation of protein transport (GO:0051224) | 0.0127726340441406 |
| odontogenesis (GO:0042476) | 0.013149167295085 |
| regulation of catabolic process (GO:0009894) | 0.013149167295085 |
| regulation of intracellular transport (GO:0032386) | 0.013149167295085 |
| osteoblast differentiation (GO:0001649) | 0.013149167295085 |
| response to external stimulus (GO:0009605) | 0.013488723194759 |
| response to chemical stimulus (GO:0042221) | 0.0135719028201621 |
| specific RNA polymerase II transcription factor activity (GO:0003704) | 0.0135719028201621 |
| lipid transport (GO:0006869) | 0.0137411716152857 |
| phospholipid transporter activity (GO:0005548) | 0.0138928095451297 |
| protein C-terminus binding (GO:0008022) | 0.0139084537922828 |
| regulation of RNA metabolic process (GO:0051252) | 0.0139663668696313 |
| ureteric bud development (GO:0001657) | 0.0139663668696313 |
| regulation of transforming growth factor beta receptor signaling pathway (GO:0017015) | 0.0139663668696313 |
| small conjugating protein ligase activity (GO:0019787) | 0.0142028706438876 |
| GABA receptor activity (GO:0016917) | 0.0147133476257452 |
| neurotransmitter binding (GO:0042165) | 0.014891087781284 |
| induction of apoptosis (GO:0006917) | 0.0149770933202901 |
| morphogenesis of an epithelium (GO:0002009) | 0.0149922505498395 |
| response to drug (GO:0042493) | 0.0149922505498395 |
| regulation of blood pressure (GO:0008217) | 0.0150794000102861 |
| calcium ion transport (GO:0006816) | 0.0150842573219211 |
| induction of programmed cell death (GO:0012502) | 0.016245978064151 |
| positive regulation of adenylate cyclase activity (GO:0045762) | 0.016284625256078 |
| positive regulation of cyclase activity (GO:0031281) | 0.016284625256078 |
| gamma-aminobutyric acid signaling pathway (GO:0007214) | 0.016284625256078 |
| positive regulation of lyase activity (GO:0051349) | 0.016284625256078 |
| steroid metabolic process (GO:0008202) | 0.0163039099715831 |
| embryonic limb morphogenesis (GO:0030326) | 0.0166362837360347 |
| embryonic appendage morphogenesis (GO:0035113) | 0.0166362837360347 |
| protein methyltransferase activity (GO:0008276) | 0.0169440378498206 |
| sarcomere (GO:0030017) | 0.0169440378498206 |
| protein complex binding (GO:0032403) | 0.0169542339296764 |
| cell cycle arrest (GO:0007050) | 0.0169542339296764 |
| neural crest cell differentiation (GO:0014033) | 0.017570495130009 |
| positive regulation of cellular component organization and biogenesis (GO:0051130) | 0.017570495130009 |
| neural crest cell development (GO:0014032) | 0.017570495130009 |
| smoothened signaling pathway (GO:0007224) | 0.017570495130009 |
| cAMP binding (GO:0030552) | 0.017570495130009 |
| anchored to plasma membrane (GO:0046658) | 0.017570495130009 |
| muscle cell proliferation (GO:0033002) | 0.0178994523453391 |
| two-component sensor activity (GO:0000155) | 0.0178994523453391 |
| SH3 domain binding (GO:0017124) | 0.0178994523453391 |
| phosphoinositide 3-kinase regulator activity (GO:0035014) | 0.0192524988218835 |
| heart looping (GO:0001947) | 0.0192524988218835 |
| activation of MAPK activity (GO:0000187) | 0.0194696464029718 |
| sodium channel activity (GO:0005272) | 0.0194696464029718 |
| phospholipase C activity (GO:0004629) | 0.0194696464029718 |
| catabolic process (GO:0009056) | 0.0196996812311552 |
| cytokinesis (GO:0000910) | 0.0197264843455615 |
| protein phosphatase type 2A complex (GO:0000159) | 0.0197264843455615 |
| sterol metabolic process (GO:0016125) | 0.0212955668897313 |
| regulation of tube size (GO:0035150) | 0.0217642422133352 |
| regulation of blood vessel size (GO:0050880) | 0.0217642422133352 |
| protein modification by small protein conjugation (GO:0032446) | 0.0219127619734537 |
| aminoglycan metabolic process (GO:0006022) | 0.0223540004285632 |
| cell projection biogenesis (GO:0030031) | 0.0223540004285632 |
| cyclic nucleotide metabolic process (GO:0009187) | 0.0223540004285632 |
| Rho protein signal transduction (GO:0007266) | 0.0227853296316485 |
| positive regulation of locomotion (GO:0040017) | 0.0227853296316485 |
| positive regulation of cell motility (GO:0051272) | 0.0227853296316485 |
| actin filament capping (GO:0051693) | 0.0227853296316485 |
| barbed-end actin filament capping (GO:0051016) | 0.0227853296316485 |
| regulation of phosphorus metabolic process (GO:0051174) | 0.0230056881518974 |
| regulation of phosphate metabolic process (GO:0019220) | 0.0230056881518974 |
| S-adenosylmethionine-dependent methyltransferase activity (GO:0008757) | 0.0231266815748071 |
| wound healing (GO:0042060) | 0.023126769293416 |
| protein phosphatase type 2A regulator activity (GO:0008601) | 0.023126769293416 |
| mechanoreceptor differentiation (GO:0042490) | 0.023126769293416 |
| phorbol ester receptor activity (GO:0001565) | 0.023126769293416 |
| protein kinase C activity (GO:0004697) | 0.023126769293416 |
| neutral amino acid transport (GO:0015804) | 0.023126769293416 |
| anchored to membrane (GO:0031225) | 0.023126769293416 |
| inner ear receptor cell differentiation (GO:0060113) | 0.023126769293416 |
| regulation of pseudopodium formation (GO:0031272) | 0.023126769293416 |
| protein phosphatase type 2A activity (GO:0000158) | 0.023126769293416 |
| stem cell maintenance (GO:0019827) | 0.023126769293416 |
| positive regulation of heart contraction (GO:0045823) | 0.023126769293416 |
| stem cell development (GO:0048864) | 0.023126769293416 |
| paraxial mesoderm morphogenesis (GO:0048340) | 0.023126769293416 |
| regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 0.023126769293416 |
| establishment of cell polarity (GO:0030010) | 0.023126769293416 |
| pseudopodium organization and biogenesis (GO:0031268) | 0.023126769293416 |
| regulation of dephosphorylation (GO:0035303) | 0.023126769293416 |
| positive regulation of protein catabolic process (GO:0045732) | 0.023126769293416 |
| dorsal/ventral axis specification (GO:0009950) | 0.023126769293416 |
| pseudopodium formation (GO:0031269) | 0.023126769293416 |
| profilin binding (GO:0005522) | 0.023126769293416 |
| neuronal ion channel clustering (GO:0045161) | 0.023126769293416 |
| associative learning (GO:0008306) | 0.023126769293416 |
| positive regulation of pseudopodium formation (GO:0031274) | 0.023126769293416 |
| histone-arginine N-methyltransferase activity (GO:0008469) | 0.023126769293416 |
| T-tubule (GO:0030315) | 0.023126769293416 |
| protein histidine kinase activity (GO:0004673) | 0.023265028025904 |
| vesicle membrane (GO:0012506) | 0.0233701170967284 |
| vascular process in circulatory system (GO:0003018) | 0.0241810981176042 |
| reproductive developmental process (GO:0003006) | 0.02566354454231 |
| chloride transport (GO:0006821) | 0.02566354454231 |
| extracellular space (GO:0005615) | 0.0258210286725242 |
| cellular cation homeostasis (GO:0030003) | 0.0261192179840483 |
| transcription factor complex (GO:0005667) | 0.0261960422013949 |
| kidney development (GO:0001822) | 0.0266714068881108 |
| gliogenesis (GO:0042063) | 0.0266714068881108 |
| microtubule polymerization (GO:0046785) | 0.0272946691425223 |
| regulation of BMP signaling pathway (GO:0030510) | 0.0272946691425223 |
| liver development (GO:0001889) | 0.0272946691425223 |
| negative regulation of BMP signaling pathway (GO:0030514) | 0.0272946691425223 |
| positive regulation of blood pressure (GO:0045777) | 0.0272946691425223 |
| vitamin transporter activity (GO:0051183) | 0.0272946691425223 |
| neuromuscular junction development (GO:0007528) | 0.0272946691425223 |
| voltage-gated sodium channel activity (GO:0005248) | 0.0272946691425223 |
| morphogenesis of embryonic epithelium (GO:0016331) | 0.0272946691425223 |
| cAMP metabolic process (GO:0046058) | 0.0272946691425223 |
| negative regulation of actin filament depolymerization (GO:0030835) | 0.0272946691425223 |
| dystrophin-associated glycoprotein complex (GO:0016010) | 0.0272946691425223 |
| fatty acid metabolic process (GO:0006631) | 0.0276146309489759 |
| negative regulation of cellular component organization and biogenesis (GO:0051129) | 0.0276146309489759 |
| circadian rhythm (GO:0007623) | 0.0277683257624978 |
| proteoglycan metabolic process (GO:0006029) | 0.0277683257624978 |
| phosphate transport (GO:0006817) | 0.0287504688853008 |
| biopolymer catabolic process (GO:0043285) | 0.0289324655975145 |
| male gamete generation (GO:0048232) | 0.0298497718775692 |
| spermatogenesis (GO:0007283) | 0.0298497718775692 |
| fibroblast growth factor receptor signaling pathway (GO:0008543) | 0.0298497718775692 |
| SMAD binding (GO:0046332) | 0.0298497718775692 |
| signal complex assembly (GO:0007172) | 0.0298497718775692 |
| G-protein signaling, adenylate cyclase activating pathway (GO:0007189) | 0.0307978884670622 |
| nuclear lumen (GO:0031981) | 0.0308862766573661 |
| developmental maturation (GO:0021700) | 0.0312587988467305 |
| GTPase activity (GO:0003924) | 0.0312587988467305 |
| small GTPase mediated signal transduction (GO:0007264) | 0.0313221595336694 |
| inositol or phosphatidylinositol phosphodiesterase activity (GO:0004434) | 0.0315793878300366 |
| phosphoinositide phospholipase C activity (GO:0004435) | 0.0315793878300366 |
| cation homeostasis (GO:0055080) | 0.0316110334015529 |
| cellular macromolecule metabolic process (GO:0044260) | 0.0316110334015529 |
| cyclin-dependent protein kinase 5 activator complex (GO:0016533) | 0.0316110334015529 |
| translational attenuation (GO:0009386) | 0.0316110334015529 |
| acylglycerol lipase activity (GO:0047372) | 0.0316110334015529 |
| negative regulation of dendrite morphogenesis (GO:0050774) | 0.0316110334015529 |
| ISG15 conjugating enzyme activity (GO:0042296) | 0.0316110334015529 |
| calcium-dependent protein serine/threonine phosphatase activity (GO:0004723) | 0.0316110334015529 |
| A-type (transient outward) potassium channel activity (GO:0005250) | 0.0316110334015529 |
| UDP-glucose metabolic process (GO:0006011) | 0.0316110334015529 |
| cyclin-dependent protein kinase 5 activator activity (GO:0016534) | 0.0316110334015529 |
| activin receptor complex (GO:0048179) | 0.0316110334015529 |
| protein serine/threonine kinase activator activity (GO:0043539) | 0.0316110334015529 |
| phosphatidylcholine transmembrane transporter activity (GO:0008525) | 0.0316110334015529 |
| glycerol ether catabolic process (GO:0044269) | 0.0316110334015529 |
| catagen (GO:0042637) | 0.0316110334015529 |
| glutamate secretion (GO:0014047) | 0.0316110334015529 |
| triacylglycerol catabolic process (GO:0019433) | 0.0316110334015529 |
| photoreceptor inner segment (GO:0001917) | 0.0316110334015529 |
| acylglycerol catabolic process (GO:0046464) | 0.0316110334015529 |
| purine ribonucleoside diphosphate biosynthetic process (GO:0009180) | 0.0316110334015529 |
| keratan sulfate metabolic process (GO:0042339) | 0.0316110334015529 |
| peptidyl-arginine N-methylation (GO:0035246) | 0.0316110334015529 |
| purine ribonucleoside diphosphate metabolic process (GO:0009179) | 0.0316110334015529 |
| glycerolipid catabolic process (GO:0046503) | 0.0316110334015529 |
| complement component C1 complex (GO:0005602) | 0.0316110334015529 |
| photoperiodism (GO:0009648) | 0.0316110334015529 |
| purine nucleoside diphosphate metabolic process (GO:0009135) | 0.0316110334015529 |
| ribonucleoside diphosphate biosynthetic process (GO:0009188) | 0.0316110334015529 |
| ionotropic glutamate receptor signaling pathway (GO:0035235) | 0.0316110334015529 |
| purine nucleoside diphosphate biosynthetic process (GO:0009136) | 0.0316110334015529 |
| aryl hydrocarbon receptor nuclear translocator activity (GO:0005061) | 0.0316110334015529 |
| ligand-gated ion channel activity (GO:0015276) | 0.0320578492494192 |
| ligand-gated channel activity (GO:0022834) | 0.0320578492494192 |
| chromatin remodeling (GO:0006338) | 0.0320578492494192 |
| neuromuscular process (GO:0050905) | 0.0320578492494192 |
| negative regulation of cell motility (GO:0051271) | 0.0320578492494192 |
| zinc ion transport (GO:0006829) | 0.0320578492494192 |
| regulation of actin filament depolymerization (GO:0030834) | 0.0320578492494192 |
| actin filament depolymerization (GO:0030042) | 0.0320578492494192 |
| regulation of neurogenesis (GO:0050767) | 0.034341511170634 |
| female pregnancy (GO:0007565) | 0.034675951972481 |
| Ras guanyl-nucleotide exchange factor activity (GO:0005088) | 0.0349176700961678 |
| ion homeostasis (GO:0050801) | 0.0365593139177108 |
| protein phosphatase binding (GO:0019903) | 0.0365593139177108 |
| regulation of protein catabolic process (GO:0042176) | 0.0365593139177108 |
| monosaccharide binding (GO:0048029) | 0.0365593139177108 |
| neuroblast proliferation (GO:0007405) | 0.0365593139177108 |
| negative regulation of transcription factor import into nucleus (GO:0042992) | 0.0365593139177108 |
| endothelial cell differentiation (GO:0045446) | 0.0365593139177108 |
| insulin-like growth factor receptor binding (GO:0005159) | 0.0365593139177108 |
| heterophilic cell adhesion (GO:0007157) | 0.0365593139177108 |
| estrogen receptor signaling pathway (GO:0030520) | 0.0365593139177108 |
| negative regulation of protein import into nucleus (GO:0042308) | 0.0365593139177108 |
| anterior/posterior axis specification (GO:0009948) | 0.0365593139177108 |
| telencephalon development (GO:0021537) | 0.0365593139177108 |
| epithelial to mesenchymal transition (GO:0001837) | 0.0365593139177108 |
| oligodendrocyte differentiation (GO:0048709) | 0.0365593139177108 |
| protein ubiquitination (GO:0016567) | 0.0376897487066613 |
| intracellular receptor-mediated signaling pathway (GO:0030522) | 0.0377105551420269 |
| cardiac muscle cell proliferation (GO:0060038) | 0.0377105551420269 |
| basic amino acid transmembrane transporter activity (GO:0015174) | 0.0377105551420269 |
| regulation of cell volume (GO:0006884) | 0.0377105551420269 |
| dendritic spine (GO:0043197) | 0.0377105551420269 |
| transforming growth factor beta receptor activity, type I (GO:0005025) | 0.0377105551420269 |
| striated muscle cell proliferation (GO:0014855) | 0.0377105551420269 |
| positive regulation of cell projection organization and biogenesis (GO:0031346) | 0.0377105551420269 |
| paraxial mesoderm development (GO:0048339) | 0.0377105551420269 |
| acyl-CoA oxidase activity (GO:0003997) | 0.0377105551420269 |
| lamin binding (GO:0005521) | 0.0377105551420269 |
| stereocilium (GO:0032420) | 0.0377105551420269 |
| stereocilium bundle (GO:0032421) | 0.0377105551420269 |
| regulation of cell projection organization and biogenesis (GO:0031344) | 0.0377105551420269 |
| negative regulation of locomotion (GO:0040013) | 0.0383467344722763 |
| negative regulation of MAP kinase activity (GO:0043407) | 0.0383467344722763 |
| cellular chemical homeostasis (GO:0055082) | 0.0383467344722763 |
| cellular ion homeostasis (GO:0006873) | 0.0383467344722763 |
| microtubule organizing center (GO:0005815) | 0.0383676427612175 |
| microbody part (GO:0044438) | 0.0383676427612175 |
| cell projection part (GO:0044463) | 0.0383676427612175 |
| peroxisomal part (GO:0044439) | 0.0383676427612175 |
| GABA-A receptor activity (GO:0004890) | 0.0384401786722915 |
| smooth muscle contraction (GO:0006939) | 0.0384401786722915 |
| carbohydrate biosynthetic process (GO:0016051) | 0.040602216568053 |
| lipid biosynthetic process (GO:0008610) | 0.0415617637539188 |
| receptor complex (GO:0043235) | 0.0421129154050754 |
| phosphoinositide-mediated signaling (GO:0048015) | 0.0428197625788366 |
| phosphotransferase activity, nitrogenous group as acceptor (GO:0016775) | 0.0430954894606229 |
| Rho GTPase binding (GO:0017048) | 0.0430954894606229 |
| neurotransmitter metabolic process (GO:0042133) | 0.0430954894606229 |
| metalloendopeptidase activity (GO:0004222) | 0.0431528408771113 |
| chemical homeostasis (GO:0048878) | 0.0436872972616046 |
| endosome transport (GO:0016197) | 0.044352172796949 |
| intercellular junction assembly and maintenance (GO:0045216) | 0.0453431907959244 |
| growth cone (GO:0030426) | 0.0453431907959244 |
| SH2 domain binding (GO:0042169) | 0.0453431907959244 |
| enzyme activator activity (GO:0008047) | 0.045616278829792 |
| regulation of JNK activity (GO:0043506) | 0.0459014323297656 |
| thyroid hormone receptor binding (GO:0046966) | 0.0459014323297656 |
| menstrual cycle process (GO:0022602) | 0.0459014323297656 |
| glutamine metabolic process (GO:0006541) | 0.0459014323297656 |
| regulation of cell adhesion (GO:0030155) | 0.0477757514281702 |
| regulation of calcium ion transport (GO:0051924) | 0.0485203051049233 |
| negative regulation of neurogenesis (GO:0050768) | 0.0485203051049233 |
| retinal binding (GO:0016918) | 0.0485203051049233 |
| negative regulation of endothelial cell proliferation (GO:0001937) | 0.0485203051049233 |
| mannose binding (GO:0005537) | 0.0485203051049233 |
| dendrite development (GO:0016358) | 0.0485203051049233 |
| glycosaminoglycan metabolic process (GO:0030203) | 0.0488285113074147 |
| epidermal growth factor receptor signaling pathway (GO:0007173) | 0.049914697359975 |
| cellular di-, tri-valent inorganic cation homeostasis (GO:0030005) | 0.0499752242681787 |
